https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01843
Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With...
Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies
safety and tolerability